News - Immucor Achieves 1,000,000 Test Per Month Milestone
Tuesday May 25, 8:01 am Eastern Time
Company Press Release
SOURCE: Immucor, Inc.
NORCROSS, Ga., May 25 /PRNewswire/ -- Immucor, Inc. (Nasdaq: BLUD - news), the leading manufacturer of blood bank reagents and related products in North America, today announced that it has achieved a run rate of 1,000,000 tests per month on its proprietary family of blood bank automation instruments, a significant strategic milestone for the Company.
''Reaching the 1,000,000 tests per month milestone this early in our product introduction is a tremendous testimony to the acceptance of automation in the blood bank market,'' commented Edward L. Gallup, president of Immucor. ''We're also extremely pleased to announce that by the end of this month we will have installed over 50 systems in North America, ahead of our internal forecast and reinforcing Immucor's leadership position in the transfusion industry. Our rapidly growing family of automation users has validated our assumptions that the ABS2000 and the Rosys Plato offer tremendous labor savings to our customers while maintaining the quality of testing. We are truly changing the face of transfusion services.''
Gallup added, ''The incremental reagent volume associated with our first 50 instrument placements now puts the annual number of Capture tests performed in North America at more than 25 million, another milestone for the Company.''
Founded in 1982, Immucor manufactures and sells a complete line of reagents and systems used by hospitals, reference laboratories and donor centers throughout the world to detect and identify certain properties of the cell and serum components of blood prior to transfusion. Immucor markets a complete family of automated instrumentation for all market segments.
For more information on Immucor, please visit our website at immucor.com . |
